Gutjahr SB 2019 - Wski B, Glaspy JA, Comin-Anduix B, et al: Reversing melanoma cross-resistance https://www.gutjahr.xyz/story.php?title=wski-b-glaspy-ja-comin-anduix-b-et-al-reversing-melanoma-cross-resistance-11 Wski B, Glaspy JA, Comin-Anduix B, et al: Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway. PLoS One 2011, 6:e28973. Prahallad A, Sun C, Huang S, Di Nicolantonio F, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A, Bernards R: Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature 2012, 483:100?03. Fri, 14 Sep 2018 14:20:49 UTC en